Vytrus Biotech SL (VYT)

Currency in EUR
5.50
0.00(0.00%)
Delayed Data·
VYT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
VYT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.505.50
52 wk Range
2.106.05
Key Statistics
Bid/Ask
5.50 / 5.50
Prev. Close
5.5
Open
5.5
Day's Range
5.5-5.5
52 wk Range
2.1-6.05
Volume
-
Average Volume (3m)
5.23K
1-Year Change
129.17%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VYT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.65
Downside
-15.45%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Vytrus Biotech SL Company Profile

Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain. The company offers Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Photobiome a prebiotic active that stimulates the skin bacteria; Olea Vitae cellular oil for ageing; Turmeria Zen a natural active with regenerating properties for skin hydration and wrinkles on stressed profiles; Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins; Deobiome Noni, a prebiotic deodorant to reduces the generation of body odour; and Sarcoslim Re-Shape an active ingredient to reduce fat on tissue. It also offers Capilia Longa a natural active ingredient to improve density in hair, eyebrows, and eyelashes through a biological approach; Luminia Granatum for skin brightening, whitens dark spots, evens skin tone, and protection against oxidative stress; Elaya Renova a natural active that boosts hair tensegrity; Kannabia Sense a prebiotic treatment that stimulates the skin microbiota to produce an in-situ postbiotic cocktail; Quora Noni to avoid the attack of skin harmful bacteria; Quora Noni biomics for rejuvenating the skin microbiota; Centella Reversa for facial complexion improvement; and Arabian Cotton an active that provides photoprotection against UV, IR, and VIS radiation, and fights against photo-ageing. In addition, the company offers Baolift a novel skincare approach to enhance skin's molecular mechanisms and improve muscle tone and facial complexion; and Clarivine to activate skin’s regeneration processes. Further, it provides Vytrus TV to create an audiovisual space with added value for cosmetic formulation. Vytrus Biotech, S.A. was incorporated in 2009 and is based in Barcelona, Spain.

Compare VYT to Peers and Sector

Metrics to compare
VYT
Peers
Sector
Relationship
P/E Ratio
40.5x16.1x12.2x
PEG Ratio
0.600.320.03
Price/Book
5.7x2.0x1.5x
Price / LTM Sales
6.8x1.1x0.9x
Upside (Analyst Target)
−15.5%14.5%17.7%
Fair Value Upside
Unlock23.5%11.3%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.65
(-15.45% Downside)

Earnings

Latest Release
Mar 25, 2025
EPS / Forecast
0.07 / --
Revenue / Forecast
3.06M / --
EPS Revisions
Last 90 days

VYT Income Statement

People Also Watch

13.300
REP
+1.76%
3.2050
SABE
+1.26%
12.852
GRLS
-1.02%
36.390
IDR
-0.41%
17.900
RTA4
+0.56%

FAQ

What Stock Exchange Does Vytrus Biotech Trade On?

Vytrus Biotech is listed and trades on the Madrid Stock Exchange stock exchange.

What Is the Stock Symbol for Vytrus Biotech?

The stock symbol for Vytrus Biotech is "VYT."

What Is the Vytrus Biotech Market Cap?

As of today, Vytrus Biotech market cap is 41.38M.

What Is Vytrus Biotech's Earnings Per Share (TTM)?

The Vytrus Biotech EPS (TTM) is 0.14.

From a Technical Analysis Perspective, Is VYT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Vytrus Biotech Stock Split?

Vytrus Biotech has split 0 times.

How Many Employees Does Vytrus Biotech Have?

Vytrus Biotech has 37 employees.

What is the current trading status of Vytrus Biotech (VYT)?

As of 06 Aug 2025, Vytrus Biotech (VYT) is trading at a price of 5.50, with a previous close of 5.50. The stock has fluctuated within a day range of 5.50 to 5.50, while its 52-week range spans from 2.10 to 6.05.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.